CLARASSANCE INC has a total of 33 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, Brazil and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are MEDESTEA RES & PRODUCTION S P A, INST SUPERIORE DI SANITA and MAXYGEN HOLDINGS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Brazil | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Israel | 3 | |
#6 | New Zealand | 3 | |
#7 | Canada | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | Singapore | 2 | |
#12 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Pilon Aprile L | 27 |
#2 | Winn Melissa E | 7 |
#3 | Flamand Louis Ph D | 6 |
#4 | Borgeat Pierre Ph D | 5 |
#5 | Clayton Richard S | 4 |
#6 | Hariprakasha Humcha K | 4 |
#7 | Flamand Louis | 3 |
#8 | Zehmer John K | 3 |
#9 | Borgeat Pierre | 3 |
#10 | Aprile L Pilon | 2 |
Publication | Filing date | Title |
---|---|---|
AU2015204387A1 | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis | |
US2014274915A1 | Methods of Use for Recombinant Human Secretoglobins | |
US2014275477A1 | Modification and compositions of human secretoglobin proteins | |
NZ588895A | Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis | |
US2009197808A1 | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |